Comparison of the enteric mucosal immunomodulatory activity of combinations of coptis chinensis Franch. Rhizomes and evodia rutaecarpa (Juss.) Benth. Fruits in mice with dextran sulphate sodium-induced ulcerative colitis

Planta Medica

Volumn 76, Issue 8, 2010, Pages 766-772

  Luo, Yingying ^a   Zhao, Hongyan ^b   Liu, Zhenli ^b   Ju, Dahong ^b   He, Xiaojuan ^b   Xiao, Cheng ^c   Zhong, Guoyue ^d   Chen, Shilin ^e   Yang, Dajian ^e   Chan, Albert Sun Chi ^e   Lu, Aiping ^b,e,f  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c China Japan Hospital   (China)

^d Chongqing Academy of Social Sciences   (China)

^e State Key Laboratory of Chinese Medicine and Molecular Pharmacology   (China)

^f SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Coptis chinensis Franch.; Evodia rutaecarpa (Juss.) Benth.; Mice; Ranunculaceae; Rutaceae; Ulcerative colitis

Indexed keywords

COPTIS CHINENSIS EXTRACT; DEXTRAN SULFATE; EVODIA RUTAECARPA EXTRACT; GASTROINTESTINAL AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; COPTIS; COPTIS CHINENSIS; DOSE RESPONSE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; EVODIA; EVODIA RUTAECARPA; FRUIT; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PEYER PATCH; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLITIS, ULCERATIVE; DEXTRAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNITY, MUCOSAL; MALE; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; RANUNCULACEAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RUTACEAE;

COPTIS CHINENSIS; EVODIA RUTAECARPA; MUS; RANUNCULACEAE; RUTACEAE;

EID: 77952894552     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0029-1240701     Document Type: Article

References (33)

1. Sun W J., Zhang Y J., Yao N, Jiang H, Wang Q. Influence on rat intestinal absorption of huanglian alkalis after match-pair of huanglian-wuzhuyu. Zhongguo Zhong Yao Za Zhi 2008 33 2614-2616
2. Xiao S, Du L, Wang Z, Bi K, Chen D, Yang Z. Research and development of wuzhuyu decoction. Zhongguo Zhong Yao Za Zhi 1999 24 503-504
3. Hirano H, Osawa E, Yamaoka Y, Yokoi T. Gastric-mucous membrane protection activity of coptisine derivatives. Biol Pharm Bull 2001 24 1277-1281
4. Hamasaki N, Ishii E, Tominaga K, Tezuka Y, Nagaoka T, Kadota S, Kuroki T, Yano I. Highly selective antibacterial activity of novel alkyl quinolone alkaloids from a Chinese herbal medicine, Gosyuyu (Wu-Chu-Yu), against Helicobacter pylori in vitro. Microbiol Immunol 2000 44 9-15
5. Karlinger K, Gyrke T, Mak E, Mester A, Tarjn Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000 35 154-167
6. MacDonald T T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005 307 1920-1925
7. Yu Y, Sitaraman S, Gewirtz A T. Intestinal epithelial cell regulation of mucosal inflammation. Immunol Res 2004 29 55-68
8. Hong Y, Hui S C., Chan T Y., Hou J Y. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am J Chin Med 2002 30 589-599
9. Lee T J., Kim E J., Kim S, Jung E M., Park J W., Jeong S H., Park S E., Yoo Y H., Kwon T K. Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol Cancer Ther 2006 5 2398-2407
10. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990 98 694-702
11. Krawisz J E., Sharon P, Stenson W F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984 87 1344-1350
12. Todd D, Singh A J., Greiner D L., Mordes J P., Rossini A A., Bortell R. A new isolation method for rat intraepithelial lymphocyte. J Immunol Methods 1999 224 111-127
13. Xiao C, Lu C, Zhao L, Liu Z, Zhang W, He Y, Chen S, Tang J C., Chan A S., Lu A. The effects of triptolide on enteric mucosal immune responses of DBA/1 mice with collagen-induced arthritis. Planta Med 2006 72 1268-1272
14. Elson C O., Sartor R B., Tennyson G S., Riddell R H. Experimental models of inflammatory bowel disease. Gastroenterology 1995 109 1344-1367
15. Mayer L. Mucosal immunity and gastrointestinal antigen processing. J Pediatr Gastroenterol Nutr 2000 30 S4-S12
16. Nagler-Anderson C, Shi H N. Peripheral nonresponsiveness to orally administered soluble protein antigens. Crit Rev Immunol 2001 21 121-131
17. Powrie F. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 1995 3 171-174
18. Podolsky D K. Lessons from genetic models of inflammatory bowel disease. Acta Gastroenterol Belg 1997 60 163-165
19. Coombes J L., Maloy K J. Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin Immunol 2007 19 116-126
20. + CD28 regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 2006 131 1775-1785
21. Allez M, Brimnes J, Dotan I, Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 2002 123 1516-1526
22. Yu Q T., Saruta M, Avanesyan A, Fleshner P R., Banham A H., Papadakis K A. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007 13 191-199
23. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Zeitz M, Duchmann R. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005 128 1868-1878
24. Brimnes J, Allez M, Dotan I, Shao L, Nakazawa A, Mayer L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol 2005 174 5814-5822
25. Funakoshi K, Sugimura K, Sasakawa T, Bannai H, Anezaki K, Ishizuka K, Yoshida K, Narisawa R, Asakura H. Study of cytokines in ulcerative colitis. J Gastroenterol 1995 30 61-63
26. Guimbaud R, Bertrand V, Chauvelot-Moachon L, Quartier G, Vidon N, Giroud J P., Couturier D, Chaussade S. Network of inflammatory cytokines and correlation with disease activity in ulcerative colitis. J Gastroenterol 1998 93 2397-2404
27. Ma T Y., Iwamoto G K., Hoa N T., Akotia V, Pedram A, Boivin M A., Said H M. TNF - induced increase in intestinal epithelial tight junction permeability requires NF-B activation. Am J Physiol Gastrointest Liver Physiol 2004 286 G367-G376
28. Sangfelt P, Carlson M, Thrn M, Xu S, Lf L, Raab Y. Local release of human neutrophil lipocalin (HNL), IL-8, and TNF- is decreased as response to topical prednisolone treatment in distal ulcerative colitis and proctitis. Dig Dis Sci 2002 47 2064-2069
29. Rutgeerts P, Sandborn W J., Feagan B G., Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer S B., Lichtenstein G R., de Villiers W J. S., Present D, Sands B E., Colombel J F. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005 353 2462-2476 (Pubitemid 41770166)
30. Regueiro M, Curtis J, Plevy S. Infliximab for hospitalized patients with severe ulcerative colitis. J Clin Gastroenterol 2006 40 476-481
31. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries J E., Roncarolo M G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 389 737-742
32. Jijon H B., Churchill T, Malfair D, Wessler A, Jewell L D., Parsons H G., Madsen K L. Inhibition of poly (ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 2000 279 G641-G651
33. Van Montfrans C, Rodriguez Pena M S. R., Pronk I, Ten Kate F J. W., Te Velde A A., Van Deventer S J. H. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology 2002 123 1865-1876